Jyunichi Koyanagi
Josai University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jyunichi Koyanagi.
European Journal of Medicinal Chemistry | 2002
Hang-Ji Quan; Jyunichi Koyanagi; Koichi Ohmori; Shinichi Uesato; Tetsuaki Tsuchido; Setsuo Saito
(3beta,20S,22S,25R)-22-Thiospirosol-5-en-3-ol (9) and (3beta,20S,22S,25R)-22-seleno-spirosol-5-en-3-ol (11) were prepared from diosgenin (3) via 26-iodopseudodiosgenin (6) as a key intermediate. Diosgenone (15), solasodinone (16), (20S,22S,25R)-22-thio-spirosol-4-en-3-one (17), (20S,22S,25R)-22-selenospirosol-4-en-3-one (18) and (20R,22S,25R)-spirosol-4-en-3-one (19) were prepared by Oppenauer oxidation of 3, solasodine 4, 9, 11 and (3beta,20R,22R,25R)-spirosol-5-en-3-ol 14, respectively. Oxidations of 15 and 16 with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) provided corresponding dienone products, (20S,22S,25R)-spirosol-1,4-dien-3-one (20) and (20S,22S,25R)-22-thiospirosol-1,4-dien-3-one (21), respectively, while oxidation of 19 (C-20 diastereoisomer of 15) gave no dienone product but 21-exo vinyl product 22. 26-Thioacetylpseudodiosgenone (24) and 26-cyanoselenopseudodiosgenone (25) were prepared by treatment of 26-iodopseudodiosgenose (23), which was obtained by Oppenauer oxidation of 6, with potassium thioacetate and potassium selenocyanate, respectively. Compounds 15 and 19 exhibited more than 80% inhibitions in INF-gamma productions at 10.0 microM. Compounds 4 and 25 showed cytotoxic activities (IC(50) = 6 and 5 microM, respectively) against cancerous HCT 116 cell lines. Compounds 12 and 25 had antiurease activities (IC(50) = 12.4 and 11.4 microM, respectively), in which only the latter showed an inhibition zone (mean zone diameter = 12.2 mm) formed by Bacillus subtilis 168 trp.
Bioscience, Biotechnology, and Biochemistry | 2006
Masayuki Ogawa; Jyunichi Koyanagi; Aiko Sugaya; Tadashi Tsuda; Hiromi Ohguchi; Kouji Nakayama; Katsumi Yamamoto; Akira Tanaka
We investigated the cytotoxic activity of 2-substituted naphtho[2,3-b]furan-4,9-diones. We have previously synthesized 33 types of 2-substituted and related compounds, and the cytotoxic activity of these compounds was then examined by a KB cell culture assay. 2-(3-Furanoyl)benzoic acids and 1,4-naphthoquinones had no activity. 2-Acetyl-4,9-dimethoxynaphtho[2,3-b]furan 4 showed low activity. However, parent naphtho[2,3-b]furan-4,9-dione 2 and most 2-substituted derivatives exhibited cytotoxic activity. The parent structure was therefore for cytotoxicity. 2-Formylnaphtho[2,3-b]furan-4,9-dione 11 had particularly potent activity (ED50=0.09 μg/ml).
Anticancer Research | 2009
Ayako Takano; Ken Hashimoto; Masayuki Ogawa; Jyunichi Koyanagi; Teruo Kurihara; Hidetsugu Wakabayashi; Hirotaka Kikuchi; Yukio Nakamura; Noboru Motohashi; Hiroshi Sakagami; Katsumi Yamamoto; Akira Tanaka
European Journal of Medicinal Chemistry | 2005
Hong-Ji Quan; Jyunichi Koyanagi; Fusao Komada; Setsuo Saito
Cancer Letters | 2005
Guang-zhu Jin; Hong-Ji Quan; Jyunichi Koyanagi; Kazuhiro Takeuchi; Yoshihiko Miura; Fusao Komada; Setsuo Saito
Journal of Heterocyclic Chemistry | 1997
Jyunichi Koyanagi; Katsumi Yamamoto; Kouji Nakayama; Akira Tanaka
Journal of Heterocyclic Chemistry | 1994
Jyunichi Koyanagi; Katsumi Yamamoto; Kouji Nakayama; Akira Tanaka
Chemical & Pharmaceutical Bulletin | 2006
Hong-Ji Quan; Jyunichi Koyanagi; Ken Hagiwara; Xing-Ri Cui; Yasunori Isshiki; Seiichi Kondo; Fusao Komada; Setsuo Saito
Journal of Heterocyclic Chemistry | 1997
Jyunichi Koyanagi; Katsumi Yamamoto; Kouji Nakayama; Akira Tanaka
Journal of Heterocyclic Chemistry | 1999
Masayuki Ogawa; Jyunichi Koyanagi; Katsuya Sakuma; Akira Tanaka; Katsumi Yamamoto